Decitabine–cedazuridine for untreated acute myeloid leukaemia when intensive chemotherapy is unsuitable (terminated appraisal)

  • Technology appraisal
  • TA932
  • Published: 

History

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators: 6135